Unpacking Policy Options to Promote Prescription Drug Affordability


Kirsten Axelsen American Enterprise Institute, Visiting Fellow

kjacarmel@gmail.com   202-862-5920

Lovisa Gustafsson The Commonwealth Fund, Assistant Vice President


Kristi Martin Waxman Strategies, Managing Director


James C. Robinson University of California Berkley, Leonard D. Schaeffer Professor of Health Economics and Director of Berkeley Center for Health Technology



Experts and Analysts

Gerard Anderson Johns Hopkins University Center for Hospital Finance and Management, Director and Professor of Health Policy and Management

ganderson@jhu.edu   410-955-3241

Juliette Cubanski Kaiser Family Foundation, Associate Director of the Program on Medicare Policy

jcubanski@kff.org   650-854-9400

Stacie Dusetzina Vanderbilt University Medical Center, Associate Professor of Health Policy and Ingram Associate Professor of Cancer Research

s.dusetzina@vanderbilt.edu   615-875-9281

Adam Fein Drug Channels Institute, Chief Executive Officer


Lance Grady   Avalere Health, Vice President of Market Access and Reimbursement

lgrady@avalere.com   202-459-6276

Tara O’Neill-Hayes American Action Forum, Deputy Director of Health Care Policy
thayes@americanactionforum.org   202-441-9745
Jack Hoadley Georgetown University Health Policy Institute, Research Professor Emeritus

jfh7@georgetown.edu   202-687-1055

Benedic Ippolito American Enterprise Institute, Research Fellow in Economic Policy Studies

Benedic.Ippolito@aei.org   202-862-5828

Elizabeth Jungman The Pew Charitable Trusts, Director of Public Health Programs

ejungman@pewtrusts.org   202-540-6443

Mark Miller Arnold Ventures, Executive Vice President of Health Care


Ameet Sarpatwari Harvard Medical School, Instructor in Medicine; Brigham Women’s Hospital, Assistant Director of the Program on Regulation, Therapeutics, And Law in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine

asarpatwari@partners.org   443-622-7908

Gillian Woollett


Avalere Health, Senior Vice President of the FDA Practice

gwoollett@avalere.com   202-207-1300





Anna Abram U.S. Food and Drug Administration, Deputy Commissioner for Policy, Planning, Legislation and Analysis


John Brooks U.S. Department of Health and Human Services, Senior Adviser to the Secretary for Drug Pricing Reform

John.Brooks@cms.hhs.gov   202-690-5400

John Coster Center for Medicaid and CHIP Services, Director, Division of Pharmacy

John.Coster@cms.hhs.gov   410-786-3000

Kate Goodrich Centers for Medicare & Medicaid Services, Chief Medical Officer and Director of the Center for Clinical Standards and Quality 

kate.goodrich@cms.hhs.gov   410-786-5533

Paul Masi Medicare Payment Advisory Commission, Assistant Director

pmasi@medpac.gov   202-220-3700



Lauren Aronson Campaign for Sustainable Drug Pricing (CSRxP), Executive Director

laronson@mc-dc.com   202-403-8621

Holly Campbell Pharmaceutical Research and Manufacturers of America, Deputy Vice President of Public Affairs


Robert Dubois National Pharmaceutical Council, Chief Science Officer and Executive Vice President

rdubois@npcnow.org   202-827-2079

Jonathan Heafitz


Pharmaceutical Care Management Association, Vice President of Federal Affairs

jheafitz@pcmanet.org   202-756-5735

Eleanor Perfetto National Health Council, Senior Vice President of Strategic Initiatives

eperfetto@nhcouncil.org   202-360-1681

Natalie Pons


OptumRx, General Counsel of Policy and Regulatory Affairs

natalie.pons@optum.com   952-205-6103  

Leigh Purvis AARP Health Policy Institute, Director of Health Services Research

lpurvis@aarp.org   202-434-3890

Murray Ross Kaiser Permanente Institute for Health Policy, Director


Lori Shoaf Blue Cross Blue Shield Association, Managing Director of Federal Relations


Judith Stein Center for Medicare Advocacy, Executive Director

jstein@medicareadvocacy.org   860-456-7790